Product Information
NAPROXEN SODIUM 220 MG TABLET is a generic product labeled by Time-Cap Labs Inc., priced at $0.0673 per EA under NDC 49483060905. Its NADAC has been published 515 times since Nov 23, 2016.
FDA first approved this application on Mar 16, 2011.
Strength
220 mg/1
Manufacturer
Time-Cap Labs Inc.NDC
49483060905
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NAPROXEN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA090545FDA Approved
3/16/2011
On Market Since
3/28/2016
Pharmacological Classes
Price Statistics
The NADAC for NAPROXEN SODIUM 220 MG TABLET has been published 515 times since Nov 23, 2016, and over the history we have for it it has risen 15.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0673 per EA |
|---|---|
| All-time high | $0.0683 (Aug 12, 2026) |
| All-time low | $0.0514 (Apr 21, 2021) |
| 52-week high | $0.0683 |
| 52-week low | $0.0635 |
| Median price | $0.0568 |
| Average price | $0.0589 |
| Largest weekly change | +12.4% (Sep 21, 2022) |
| Weeks tracked | 515 |
| Tracking since | Nov 23, 2016 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Time-Cap Labs Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
NAPROXEN SODIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NAPROXEN SODIUM 220 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN SODIUM 220 MG TABLET, manufactured by Time-Cap Labs Inc., is $0.0673 per EA (NDC 49483060905), effective Sep 30, 2026.
How has the price of NAPROXEN SODIUM 220 MG TABLET changed over time?
Over the history we have for it, the NADAC for NAPROXEN SODIUM 220 MG TABLET has risen 15.9%. It has been tracked across 515 weekly CMS publications since Nov 23, 2016.
What are the highest and lowest recorded NADAC prices for NAPROXEN SODIUM 220 MG TABLET?
Since Nov 23, 2016, the NADAC for NAPROXEN SODIUM 220 MG TABLET has ranged from a low of $0.0514 (Apr 21, 2021) to a high of $0.0683 (Aug 12, 2026), with a median of $0.0568 per EA.
Are there cheaper alternatives to NAPROXEN SODIUM 220 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC NAPROXEN SOD 220 MG CAPLET, is $0.0644 per EA — about 4% below NAPROXEN SODIUM 220 MG TABLET.
Who manufactures NAPROXEN SODIUM 220 MG TABLET?
NAPROXEN SODIUM 220 MG TABLET (NDC 49483060905) is labeled by Time-Cap Labs Inc., and CMS classifies it as a generic product.